Dr. Scott A. Dorroh, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4808 E Johnson Ave, Hem/onc Dept., Jonesboro, AR 72401 Phone: 870-936-7000 Fax: 870-934-3677 |
Mazen Khalil, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 300 Carson St, Jonesboro, AR 72401 Phone: 870-932-5296 Fax: 870-910-7713 |
Ronald J Blachly, M.D. Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 4808 E Johnson Ave, Jonesboro, AR 72401 Phone: 870-936-7000 Fax: 870-934-3677 |
David A Nixon, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4808e Johnson Ave, Jonesboro, AR 72401 Phone: 870-936-7000 Fax: 870-934-3677 |
Carroll D. Scroggin, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4808e Johnson Ave, Jonesboro, AR 72401 Phone: 870-936-7000 Fax: 870-934-3677 |
News Archive
Dental problems are the most commonly cited unmet need among children. Cedars-Sinai's COACH for Kids and Their Families, a mobile medical program, has been selected as one of 20 school-based programs nationwide to receive a grant from the National Assembly on School-based Health Care (NASBHC) to increase oral health services to students in underserved communities.
News outlets report that the changes to Medicaid proposed by likely GOP vice presidential nominee Rep. Paul Ryan would have immediate and far-reaching consequences for millions of people, including poor seniors.
It is known that women with PCOS have a 3-fold increase in their risk of developing type-2 diabetes, where the body does not produce enough insulin or cannot use insulin properly. Insulin resistance is an important factor in the condition, which is the most common female hormone disorder. PCOS affects between 5 and 10 per cent of women and is a major cause of infertility.
Aston Academy of Life Sciences, the clinical research hospital of Aston University, has recently been commissioned to assess the efficacy and safety of a specialist drug, Posurdex (Allergan Ltd, UK), which is used in the treatment of patients who suffer from a sight threatening condition, called macular oedema.
› Verified 9 days ago